Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
Apr. 15 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
2023 | Canntab Therapeutics Limited Provide an Update on Product Delivery | CI |
Sales 2021 | - | Sales 2022 | 0.29 0.4 | Capitalization | 11.48M 15.79M |
---|---|---|---|---|---|
Net income 2021 | -4M -5.5M | Net income 2022 | -3M -4.13M | EV / Sales 2021 | - |
Net Debt 2021 | 75.05K 103K | Net Debt 2022 | 1.15M 1.58M | EV / Sales 2022 | 43,043,762 x |
P/E ratio 2021 |
-7.9
x | P/E ratio 2022 |
-3.02
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 86.26% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 16-04-19 | |
President | 56 | 16-04-19 | |
Chief Tech/Sci/R&D Officer | - | 20-05-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
President | 56 | 16-04-19 | |
Barry Polisuk
BRD | Director/Board Member | 61 | 18-04-10 |
Vitor Fonseca
BRD | Director/Board Member | 71 | 18-04-10 |
Date | Price | Change | Volume |
---|
Delayed Quote Canadian Securities Exchange, October 04, 2023 at 02:07 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-.--% | 141K | |
+37.12% | 6B | |
-14.61% | 4.42B | |
-10.58% | 3.06B | |
+0.86% | 2.99B | |
-0.94% | 2.48B | |
+36.18% | 1.78B | |
-10.82% | 1.58B | |
-4.89% | 1.52B | |
-12.50% | 1.49B |
- Stock Market
- Equities
- PILL Stock